| Code | Description | Claims | Beneficiaries | Total Paid |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,277 |
1,154 |
$104K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,613 |
1,451 |
$88K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,756 |
2,155 |
$84K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,106 |
1,731 |
$42K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
394 |
326 |
$20K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
825 |
713 |
$9K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
996 |
779 |
$4K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
44 |
39 |
$2K |
| J2010 |
Injection, lincomycin hcl, up to 300 mg |
201 |
171 |
$1K |
| 87807 |
|
20 |
18 |
$205.67 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
500 |
451 |
$188.72 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
54 |
53 |
$49.77 |
| 99072 |
|
380 |
240 |
$0.00 |